Jennifer L. Good, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 74,482 shares at $50.45 ($3.8M) on 2024-09-09, disclosed to the SEC on 2024-09-11.
Scheduled sale ($3.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.45 | 37,241 | $1.9M | 50.0% |
| 2 | $50.45 | 37,241 | $1.9M | 50.0% |
| Total | $50.45 avg | 74,482 | $3.8M | 100% |
| Filing → |
| TRVI | SELL | 2024-09-09 | $18K | — | Filing → |
| TRVI | SELL | 2024-09-05 | $295K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $1.5M | — | Filing → |